Summary

The global pharmaceutical filtration market is projected to reach USD 21.75 billion by 2030 from an estimated USD 14.35 billion in 2025, at a CAGR of 8.7% from 2025 to 2030. The expansion of the pharmaceutical filtration market has been predominantly fueled by the tightening global regulatory expectations for sterility and viral safety. However, technological limitations are expected to restrict the market.

https://mnmimg.marketsandmarkets.com/Images/pharmaceutical-filtration-market-img-overview.webp

In 2024, sterile filtration was the fastest-growing segment in the pharmaceutical filtration market by type.
The sterile filtration segment was the fastest-growing segment in the pharmaceutical filtration market, by type, primarily because of the growing emphasis on developing advanced therapeutic solutions and the rapid progress being made in biomedical research. As research activities expand, the need to maintain strictly sterile environments during drug development and manufacturing becomes increasingly critical. This has significantly boosted the adoption of sterile filtration technologies, which play a vital role in preventing microbial contamination, preserving product integrity, and ensuring compliance with stringent regulatory standards. These systems are essential for safeguarding the quality of biopharmaceuticals at various stages of production, particularly during cell culture preparation, upstream processing, and final formulation.
Another major contributor to the segment’s growth is the rising number of approvals for biologics and biosimilars. As more complex and sensitive biological molecules enter the market, demand intensifies for reliable sterile filtration methods capable of managing high-throughput workflows without compromising sterility assurance. These biologics require robust filtration processes to remove microorganisms efficiently while maintaining structural stability and therapeutic effectiveness.
Additionally, global expansion in vaccine manufacturing, driven by the need to address infectious diseases and emerging health threats, has further strengthened the demand for sterile filtration. Vaccine production heavily depends on high-performance filtration systems to eliminate contaminants and ensure safe, sterile end products. Together, these factors have firmly positioned sterile filtration as the fastest-growing segment within the pharmaceutical filtration market.


The final product processing segment reported the highest share of the application segment in 2024.

Within the application segment, the pharmaceutical filtration market is divided into final product processing, raw material filtration, cell separation, water purification, and air purification.
In 2024, final product processing emerged as both the largest and the fastest-expanding application area in the pharmaceutical filtration industry. This dominance is primarily driven by rising regulatory expectations for product purity, sterility assurance, and contamination control throughout the final stages of drug manufacturing. As the biopharmaceutical sector continues to expand rapidly, particularly in the production of monoclonal antibodies, cell- and gene-based therapies, and vaccine platforms, the need for high-performance filtration solutions has grown significantly. Additionally, the steady increase in biologics and biosimilar production has intensified the requirement for efficient and validated filtration systems to ensure consistent quality and regulatory compliance. Collectively, these factors reinforce the strong growth trajectory of the final product processing segment within the global pharmaceutical filtration market.

North America accounted for the largest market share in the global pharmaceutical filtration market in 2024.

North America maintains its dominant position in the pharmaceutical filtration market due to its strong biopharmaceutical manufacturing ecosystem and rapid adoption of advanced filtration technologies. The region hosts numerous global pharma leaders, innovative biotech firms, and large CDMOs, all of which require high-performance filtration systems to support biologics, vaccines, and cell and gene therapy production. Strict regulatory standards imposed by the FDA drive continuous upgrades in membrane technologies, sterile filtration systems, and automated quality-control tools. Significant investment in R&D, coupled with a high volume of clinical trials, supports steady demand for cutting-edge filtration solutions. North America also benefits from a well-established pharmaceutical infrastructure, skilled bioprocessing talent, and extensive capacity expansions by major filtration suppliers. Government initiatives promoting biomanufacturing resilience, pandemic preparedness, and next-generation therapies further strengthen the region’s leadership, ensuring sustained technological advancement and market growth in pharmaceutical filtration.

The primary interviews conducted for this report can be categorized as follows:

? By Respondent: Supply Side-70% and Demand Side-30%
? By Designation: Managers-45%, CXO and Directors-30%, and Executives-25%
? By Region: North America-40%, Europe-25%, the Asia Pacific-25%, Latin America-5%, and the Middle East & Africa-5%
Key Companies Profiled in the Report
Key players in the Pharmaceutical filtration market include Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), Solventum (US), Repligen Corporation (US), Parker Hannifin Corporation (US), Eaton Corporation plc (Ireland), Thermo Fisher Scientific Inc. (US), Donaldson Company, Inc. (US), Porvair PLC (UK), Alfa Laval Corporate AB (Sweden), Corning Incorporated (US), MANN+HUMMEL (Germany), Saint-Gobain (France), STERIS plc (US), Asahi Kasei Corporation(Japan).
Research Coverage
This research report categorizes the Pharmaceutical Filtration Market by Product (Membrane filter, Depth filter, Virus filter, Air Filter, Assemblies, Systems [Single-use]), Technique (Ultrafiltration), Type (Sterile), Application (API, Protein), Scale, End User - Global Forecast to 2030.
The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the pharmaceutical filtration market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. New approvals/launches, collaborations, acquisitions, and recent developments associated with the pharmaceutical filtration market.
Key Benefits of Buying the Report:
The report will help market leaders and new entrants by providing them with the closest approximations of the revenue numbers for the overall pharmaceutical filtration market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their businesses and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights into the following pointers:
? Analysis of key drivers (Increasing development and commercialization of biologics and biosimilars, tightening global regulatory expectations for sterility and viral safety, growing adoption of single-use filtration systems and assemblies, rising need for sterile and high-concentration drug products, and Adoption of continuous manufacturing process), restraints (High cost of advanced filtration technologies and single-use systems, technological limitations), opportunities (Integration of smart filtration with digitalization and AI-driven process and growing focus on sustainable and eco-friendly filtration solutions) and Challenges (Stringent regulatory compliance, technical and operational challenges, lack of skilled workforce).
? Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities in the pharmaceutical filtration market
? Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
? Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the pharmaceutical filtration market
? Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players. A detailed analysis of the key industry players has been done to provide insights into their key strategies, product launches/approvals, pipeline analysis, acquisitions, partnerships, agreements, collaborations, other recent developments, investment and funding activities, brand/product comparative analysis, and vendor valuation and financial metrics of the pharmaceutical filtration market.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 54
1.1 STUDY OBJECTIVES 54
1.2 MARKET DEFINITION 54
1.3 STUDY SCOPE 55
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 55
1.3.2 INCLUSIONS & EXCLUSIONS 56
1.3.3 YEARS CONSIDERED 57
1.3.4 CURRENCY CONSIDERED 57
1.4 STAKEHOLDERS 57
1.5 SUMMARY OF CHANGES 58
2 EXECUTIVE SUMMARY 59
2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 59
2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS 60
2.3 DISRUPTIVE TRENDS SHAPING MARKET 61
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 62
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 63
3 PREMIUM INSIGHTS 64
3.1 PHARMACEUTICAL FILTRATION MARKET OVERVIEW 64
3.2 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET, BY TYPE & COUNTRY 65
3.3 PHARMACEUTICAL FILTRATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 66
4 MARKET OVERVIEW 67
4.1 INTRODUCTION 67
4.2 MARKET DYNAMICS 67
4.2.1 DRIVERS 68
4.2.1.1 Rapid growth in development and commercialization of biologics and biosimilars 68
4.2.1.2 Increasing global regulatory demands for sterility and viral safety 70
4.2.1.3 Growing adoption of single-use filtration systems & assemblies 70
4.2.1.4 Rising need for sterile, high-concentration drugs 71
4.2.1.5 Adoption of continuous manufacturing process 71
4.2.2 RESTRAINTS 72
4.2.2.1 High cost of advanced filtration technologies and single-use systems 72
4.2.2.2 Technological limitations 72
4.2.3 OPPORTUNITIES 72
4.2.3.1 Smart filtration with digitalization and innovation 72
4.2.3.2 Growing focus on sustainable and eco-friendly filtration solutions 73
4.2.4 CHALLENGES 73
4.2.4.1 Stringent regulatory compliance 73
4.2.4.2 Technical and operational challenges 73
4.2.4.3 Lack of skilled workforce 74
4.3 UNMET NEEDS AND WHITE SPACES 74
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 75
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 76
5 INDUSTRY TRENDS 77
5.1 PORTER’S FIVE FORCES ANALYSIS 77
5.1.1 THREAT OF NEW ENTRANTS 78
5.1.2 THREAT OF SUBSTITUTES 78
5.1.3 BARGAINING POWER OF BUYERS 78
5.1.4 BARGAINING POWER OF SUPPLIERS 78
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 78
5.2 MACROECONOMIC OUTLOOK 79
5.2.1 INTRODUCTION 79
5.2.2 GDP TRENDS AND FORECASTS 79
5.2.3 TRENDS IN GLOBAL PHARMACEUTICAL FILTRATION MARKET 79
5.3 VALUE CHAIN ANALYSIS 80
5.4 ECOSYSTEM ANALYSIS 82
5.5 PRICING ANALYSIS 84
5.5.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS,
BY PRODUCT, 2022?2024 84
5.5.2 AVERAGE SELLING PRICE TREND, BY REGION, 2022?2024 85
5.6 TRADE ANALYSIS 86
5.6.1 IMPORT DATA FOR HS CODE 8421, 2020?2024 86
5.6.2 EXPORT DATA FOR HS CODE 8421, 2020?2024 87
5.6.3 EXPORT VOLUME FOR HS CODE 8421, 2020?2024 88
5.6.4 IMPORT VOLUME FOR HS CODE 8421, 2020?2024 89
5.7 KEY CONFERENCES & EVENTS 90
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 90
5.9 INVESTMENT/FUNDING ACTIVITY 91
5.9.1 VC/PRIVATE EQUITY INVESTMENT TRENDS & STARTUP LANDSCAPE 91
5.10 CASE STUDY ANALYSIS 92
5.11 IMPACT OF 2025 US TARIFF ON PHARMACEUTICAL FILTRATION MARKET 94
5.11.1 INTRODUCTION 94
5.11.2 KEY TARIFF RATES 94
5.11.3 PRICE IMPACT ANALYSIS 95
5.11.4 IMPACT ON COUNTRY/REGION 96
5.11.4.1 US 96
5.11.4.2 Europe 96
5.11.4.3 Asia Pacific 97
5.11.5 IMPACT ON END-USE INDUSTRIES 97
5.11.5.1 Pharmaceutical & biotechnology companies 97
5.11.5.2 CROs and CDMOs/CMOs 98
5.11.5.3 Academic & research institutes 98
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 99
6.1 TECHNOLOGY ANALYSIS 99
6.1.1 KEY TECHNOLOGIES 99
6.1.1.1 Microfiltration 99
6.1.1.2 Ultrafiltration 99
6.1.1.3 Nanofiltration 100
6.1.2 COMPLEMENTARY TECHNOLOGIES 100
6.1.2.1 Electrospun microfibers 100
6.1.2.2 Photocatalytic filtration 100
6.1.3 ADJACENT TECHNOLOGIES 101
6.1.3.1 Chromatography 101
6.1.3.2 Microfluidics 101
6.2 TECHNOLOGY/PRODUCT ROADMAP 102
6.3 PATENT ANALYSIS 103
6.3.1 TOP APPLICANTS/OWNERS (COMPANIES) FOR PHARMACEUTICAL FILTRATION PATENTS, 2014?2024 103
6.4 FUTURE APPLICATIONS 104
6.5 IMPACT OF AI/GEN AI ON PHARMACEUTICAL FILTRATION MARKET 104
6.5.1 TOP USE CASES AND MARKET POTENTIAL 105
6.5.2 CASE STUDIES OF AI IMPLEMENTATION IN PHARMACEUTICAL FILTRATION MARKET 106
6.5.3 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 106
6.5.4 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN PHARMACEUTICAL FILTRATION MARKET 106
7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES 108
7.1 REGIONAL REGULATIONS AND COMPLIANCE 108
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 108
7.1.2 REGULATORY FRAMEWORK 111
7.1.3 INDUSTRY STANDARDS 113
7.2 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES 113
7.3 CERTIFICATIONS, LABELING, & ECO-STANDARDS 114
?
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 116
8.1 DECISION-MAKING PROCESS 116
8.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 116
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 116
8.2.2 KEY BUYING CRITERIA, BY END USER 117
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 118
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 118
8.5 MARKET PROFITABILITY 119
9 PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT 120
9.1 INTRODUCTION 121
9.2 CONSUMABLES 121
9.2.1 FILTERS 124
9.2.1.1 Membrane filters 127
9.2.1.1.1 Polyethersulfone (PES) 131
9.2.1.1.1.1 Wide use of hydrophilic PES membranes in sterilizing applications to drive growth 131
9.2.1.1.2 Polyvinylidene difluoride (PVDF) 135
9.2.1.1.2.1 Nontoxic nature to increase demand for PVDF filters 135
9.2.1.1.3 Nylon 138
9.2.1.1.3.1 Increased endotoxin adsorption capacity of nylon filters to drive growth 138
9.2.1.1.4 Polytetrafluoroethylene (PTFE) 141
9.2.1.1.4.1 PTFE membrane filters offer retention of ratings as fine as 0.01μ 141
9.2.1.1.5 Mixed cellulose ester & cellulose acetate (MCE & CA) 144
9.2.1.1.5.1 MCE membranes widely used in analytical and research applications 144
9.2.1.1.6 Polycarbonate track-etched (PCTE) 148
9.2.1.1.6.1 PCTE membrane filters widely used in cell biology and analytical testing applications 148
9.2.1.1.7 Other materials 151
9.2.1.2 Depth filters 154
9.2.1.2.1 Diatomaceous Earth 157
9.2.1.2.1.1 Increasing use in biotechnology industry for cell clarification to drive market 157
9.2.1.2.2 Cellulose 160
9.2.1.2.2.1 Cost-effectiveness of cellulose-based depth filters to drive adoption 160
9.2.1.2.3 Activated carbon 163
9.2.1.2.3.1 Widely used in pharmaceutical industry to remove range of soluble impurities from process streams containing APIs 163
?
9.2.1.2.4 Perlite 166
9.2.1.2.4.1 Better suited for separating coarse micro-particles from liquids with high solids loading 166
9.2.1.2.5 Other depth filter media 169
9.2.1.3 Air filters 172
9.2.1.4 Virus filters 175
9.2.1.5 Other filters 178
9.2.2 OTHER CONSUMABLES 182
9.2.2.1 FILTRATION ASSEMBLIES 185
9.2.2.1.1 Microfiltration assemblies 188
9.2.2.1.1.1 Growing demand for high-quality products to support segment growth 188
9.2.2.1.2 Ultrafiltration assemblies 192
9.2.2.1.2.1 Stringent regulatory requirements to support segment growth 192
9.2.2.1.3 Nanofiltration assemblies 195
9.2.2.1.3.1 Increasing demand for high-purity biopharmaceuticals to propel market 195
9.2.2.1.4 Other filtration assemblies 199
9.2.2.2 FILTER HOLDERS 202
9.2.2.2.1 Filter holders provide structural support to membrane filters 202
9.2.2.3 FILTRATION ACCESSORIES 205
9.2.2.3.1 Increasing adoption of pharmaceutical filtration products to support growth 205
9.3 SYSTEMS 208
9.3.1 SINGLE-USE SYSTEMS 211
9.3.1.1 Reduced need for product validation and minimized cross-contamination risk to boost adoption 211
9.3.2 REUSABLE SYSTEMS 215
9.3.2.1 Widely used for large-scale manufacturing to drive adoption 215
10 PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE 218
10.1 INTRODUCTION 219
10.2 MICROFILTRATION 219
10.2.1 INCREASED ADOPTION OF MICROFILTRATION TO PROPEL GROWTH 219
10.3 ULTRAFILTRATION 222
10.3.1 ADOPTION OF FINE FILTRATION TECHNIQUES TO DRIVE GROWTH 222
10.4 NANOFILTRATION 224
10.4.1 RISING DEMAND IN BIOTECHNOLOGY INDUSTRY TO SUPPORT MARKET GROWTH 224
10.5 OTHER TECHNIQUES 227
?
11 PHARMACEUTICAL FILTRATION MARKET, BY TYPE 231
11.1 INTRODUCTION 232
11.2 STERILE FILTRATION 232
11.2.1 ADVANTAGES OF STERILE FILTERS OVER NON-STERILE FILTERS TO DRIVE GROWTH 232
11.3 NON-STERILE FILTRATION 235
11.3.1 GROWTH IN PHARMA R&D ACTIVITIES TO PROPEL MARKET 235
12 PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION 238
12.1 INTRODUCTION 239
12.2 FINAL PRODUCT PROCESSING 239
12.2.1 ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION 243
12.2.1.1 Continuous requirement for API filtration to drive market 243
12.2.2 PROTEIN PURIFICATION 247
12.2.2.1 Recent advancements in protein therapeutic drugs to propel growth 247
12.2.3 VACCINE AND ANTIBODY PROCESSING 250
12.2.3.1 Development of vaccines for viral diseases to drive growth 250
12.2.4 FORMULATION AND FILLING SOLUTIONS 254
12.2.4.1 Demand for aseptic filling and bioburden reduction to propel growth 254
12.2.5 VIRAL CLEARANCE 257
12.2.5.1 Growing development of therapeutic monoclonal antibodies to drive market 257
12.3 RAW MATERIAL FILTRATION 260
12.3.1 MEDIA AND BUFFER FILTRATION 263
12.3.1.1 Growth in manufacturing of biopharmaceuticals to drive market 263
12.3.2 PREFILTRATION 267
12.3.2.1 Membrane fouling issues to drive growth 267
12.3.3 BIOBURDEN TESTING 270
12.3.3.1 Strict quality control of biopharmaceuticals to drive growth 270
12.4 CELL SEPARATION 273
12.4.1 GROWTH IN PERSONALIZED MEDICINE AND CELL THERAPIES TO PROPEL MARKET 273
12.5 WATER PURIFICATION 276
12.5.1 REQUIREMENT IN RESEARCH AND FORMULATION TO DRIVE MARKET 276
12.6 AIR PURIFICATION 279
12.6.1 INCREASING ADOPTION OF GMP PRACTICES TO DRIVE GROWTH 279
13 PHARMACEUTICAL FILTRATION MARKET, BY SCALE OF OPERATION 282
13.1 INTRODUCTION 283
13.2 MANUFACTURING-SCALE 283
13.2.1 GROWTH IN BIOLOGICS AND BIOSIMILARS MANUFACTURING TO DRIVE MARKET 283
?
13.3 PILOT-SCALE 288
13.3.1 INCREASED OUTSOURCING OF PILOT-SCALE BIOPROCESS DEVELOPMENT TO DRIVE MARKET 288
13.4 R&D-SCALE 291
13.4.1 INCREASING INVESTMENTS IN R&D OF BIOLOGICS TO PROPEL GROWTH 291
14 PHARMACEUTICAL FILTRATION MARKET, BY END USER 295
14.1 INTRODUCTION 296
14.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES 296
14.2.1 GROWING BIOLOGICS PRODUCTION TO PROPEL DEMAND 296
14.3 CROS & CMOS 300
14.3.1 GROWTH IN PHARMA R&D ACTIVITIES TO DRIVE MARKET 300
14.4 ACADEMIC & RESEARCH INSTITUTES 303
14.4.1 RISING DEMAND FOR LABORATORY FILTRATION ACROSS CROS AND RESEARCH INSTITUTES TO PROPEL MARKET 303
15 PHARMACEUTICAL FILTRATION MARKET, BY REGION 307
15.1 INTRODUCTION 308
15.2 NORTH AMERICA 308
15.2.1 NORTH AMERICA: MACROECONOMIC ANALYSIS 309
15.2.2 US 317
15.2.2.1 US to dominate North America market during forecast period 317
15.2.3 CANADA 323
15.2.3.1 Growing government support for expanding biologics manufacturing facilities to support market growth 323
15.3 EUROPE 328
15.3.1 EUROPE: MACROECONOMIC ANALYSIS 328
15.3.2 GERMANY 336
15.3.2.1 Growing pharmaceutical R&D and manufacturing to drive market 336
15.3.3 UK 342
15.3.3.1 Increased awareness of drug quality led to greater use of filtration products in drug discovery laboratories 342
15.3.4 FRANCE 348
15.3.4.1 Government investment in pharmaceutical industry to drive growth 348
15.3.5 ITALY 354
15.3.5.1 Investment in biotechnology R&D to boost market growth 354
15.3.6 SPAIN 360
15.3.6.1 Expansion of biomanufacturing facilities to support market growth 360
15.3.7 SWITZERLAND 366
15.3.7.1 Presence of key pharmaceutical and biopharmaceutical companies to support market growth 366
15.3.8 REST OF EUROPE 372
?
15.4 ASIA PACIFIC 378
15.4.1 ASIA PACIFIC: MACROECONOMIC ANALYSIS 379
15.4.2 CHINA 386
15.4.2.1 China to dominate Asia Pacific market during forecast period 386
15.4.3 JAPAN 392
15.4.3.1 Stringent regulatory guidelines to create need for advanced filtration products 392
15.4.4 INDIA 398
15.4.4.1 Favorable scenario for foreign direct investment to favor market growth 398
15.4.5 SOUTH KOREA 404
15.4.5.1 Increased export of drugs to support market growth 404
15.4.6 AUSTRALIA 410
15.4.6.1 Increasing demand for innovative filtration solutions to propel market 410
15.4.7 REST OF ASIA PACIFIC 416
15.5 LATIN AMERICA 422
15.5.1 LATIN AMERICA: MACROECONOMIC ANALYSIS 422
15.5.2 BRAZIL 429
15.5.2.1 Increased government investments in pharmaceutical R&D to drive market 429
15.5.3 MEXICO 435
15.5.3.1 Rising demand for chronic disease treatment to support market growth 435
15.5.4 REST OF LATIN AMERICA 441
15.6 MIDDLE EAST 447
15.6.1 MIDDLE EAST: MACROECONOMIC ANALYSIS 447
15.6.2 GCC COUNTRIES 454
15.6.2.1 Saudi Arabia 460
15.6.2.1.1 Growing healthcare expenditure to boost market growth 460
15.6.2.2 UAE 466
15.6.2.2.1 Adoption of more efficient and precise filtration processes to aid market growth 466
15.6.2.3 Rest of GCC Countries 472
15.6.3 REST OF MIDDLE EAST 478
15.7 AFRICA 483
15.7.1 AFRICA: MACROECONOMIC ANALYSIS 483
16 COMPETITIVE LANDSCAPE 490
16.1 INTRODUCTION 490
16.2 STRATEGIES ADOPTED BY KEY PLAYERS 490
16.3 REVENUE SHARE ANALYSIS 492
16.4 MARKET SHARE ANALYSIS 492
16.5 COMPANY EVALUATION MATRIX: KEY PLAYERS 494
16.5.1 STARS 495
16.5.2 EMERGING LEADERS 495
16.5.3 PERVASIVE PLAYERS 495
16.5.4 PARTICIPANTS 495
16.5.5 COMPETITIVE BENCHMARKING: KEY PLAYERS, 2024 497
16.5.5.1 Company footprint 497
16.5.5.2 Product footprint 498
16.5.5.3 Technique footprint 499
16.5.5.4 Application footprint 500
16.5.5.5 Regional footprint 501
16.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES 502
16.6.1 PROGRESSIVE COMPANIES 502
16.6.2 RESPONSIVE COMPANIES 502
16.6.3 DYNAMIC COMPANIES 502
16.6.4 STARTING BLOCKS 503
16.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 504
16.6.5.1 Detailed list of key startups/SMEs, 2024 504
16.6.5.2 Competitive benchmarking of key startups/SMEs, 2024 505
16.7 VALUATION AND FINANCIAL METRICS OF PHARMACEUTICAL FILTRATION VENDORS 506
16.8 BRAND/PRODUCT COMPARATIVE ANALYSIS 507
16.8.1 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY PRODUCT 507
16.9 COMPETITIVE SCENARIO 508
16.9.1 PRODUCT LAUNCHES 508
16.9.2 DEALS 509
16.9.3 EXPANSIONS 510
17 COMPANY PROFILES 511
17.1 KEY PLAYERS 511
17.1.1 MERCK KGAA 511
17.1.1.1 Business overview 511
17.1.1.2 Products offered 512
17.1.1.3 Recent developments 516
17.1.1.3.1 Expansions 516
17.1.1.4 MnM view 517
17.1.1.4.1 Key strengths 517
17.1.1.4.2 Strategic choices 517
17.1.1.4.3 Weaknesses and competitive threats 517
17.1.2 DANAHER CORPORATION 518
17.1.2.1 Business overview 518
17.1.2.2 Products offered 519
17.1.2.3 Recent developments 525
17.1.2.3.1 Product launches 525
17.1.2.3.2 Deals 525
17.1.2.3.3 Expansions 525
17.1.2.4 MnM view 526
17.1.2.4.1 Key strengths 526
17.1.2.4.2 Strategic choices 526
17.1.2.4.3 Weaknesses and competitive threats 526
17.1.3 SARTORIUS AG 527
17.1.3.1 Business overview 527
17.1.3.2 Products offered 528
17.1.3.3 Recent developments 531
17.1.3.3.1 Product launches 531
17.1.3.3.2 Deals 531
17.1.3.3.3 Expansions 531
17.1.3.4 MnM view 532
17.1.3.4.1 Key strengths 532
17.1.3.4.2 Strategic choices 532
17.1.3.4.3 Weaknesses and competitive threats 532
17.1.4 SOLVENTUM 533
17.1.4.1 Business overview 533
17.1.4.2 Products offered 534
17.1.4.3 Recent developments 536
17.1.4.3.1 Product launches 536
17.1.4.3.2 Deals 537
17.1.4.3.3 Other developments 537
17.1.4.4 MnM view 537
17.1.4.4.1 Key strengths 537
17.1.4.4.2 Strategic choices 538
17.1.4.4.3 Weaknesses and competitive threats 538
17.1.5 PARKER HANNIFIN CORPORATION 539
17.1.5.1 Business overview 539
17.1.5.2 Products offered 540
17.1.5.3 MnM view 542
17.1.5.3.1 Key strengths 542
17.1.5.3.2 Strategic choices 542
17.1.5.3.3 Weaknesses and competitive threats 542
17.1.6 REPLIGEN CORPORATION 543
17.1.6.1 Business overview 543
17.1.6.2 Products offered 544
17.1.6.3 Recent developments 546
17.1.6.3.1 Product launches 546
17.1.6.3.2 Deals 546
?
17.1.7 EATON CORPORATION PLC 547
17.1.7.1 Business overview 547
17.1.7.2 Products offered 548
17.1.7.3 Recent developments 550
17.1.7.3.1 Product launches 550
17.1.8 THERMO FISHER SCIENTIFIC, INC. 551
17.1.8.1 Business overview 551
17.1.8.2 Products offered 552
17.1.8.3 Recent developments 555
17.1.8.3.1 Deals 555
17.1.8.3.2 Expansions 555
17.1.9 DONALDSON COMPANY, INC. 557
17.1.9.1 Business overview 557
17.1.9.2 Products offered 558
17.1.9.3 Recent developments 559
17.1.9.3.1 Deals 559
17.1.9.3.2 Expansions 560
17.1.10 PORVAIR PLC 561
17.1.10.1 Business overview 561
17.1.10.2 Products offered 562
17.1.10.3 Recent developments 564
17.1.10.3.1 Product launches 564
17.1.11 ALFA LAVAL CORPORATE AB 565
17.1.11.1 Business overview 565
17.1.11.2 Products offered 566
17.1.11.3 Recent developments 567
17.1.11.3.1 Product launches 567
17.1.12 CORNING INCORPORATED 568
17.1.12.1 Business overview 568
17.1.12.2 Products offered 569
17.1.13 MANN+HUMMEL 572
17.1.13.1 Business overview 572
17.1.13.2 Products offered 573
17.1.13.3 Recent developments 574
17.1.13.3.1 Deals 574
17.1.14 SAINT-GOBAIN 575
17.1.14.1 Business overview 575
17.1.14.2 Products offered 576
17.1.14.3 Recent developments 577
17.1.14.3.1 Product launches 577
17.1.14.3.2 Expansions 577
17.1.15 STERIS PLC 578
17.1.15.1 Business overview 578
17.1.15.2 Products offered 579
17.1.16 ASAHI KASEI CORPORATION 580
17.1.16.1 Business overview 580
17.1.16.2 Products offered 581
17.1.16.3 Recent developments 581
17.1.16.3.1 Product launches 581
17.1.16.3.2 Deals 582
17.1.16.3.3 Expansions 582
17.2 OTHER PLAYERS 583
17.2.1 MEISSNER FILTRATION PRODUCTS, INC. 583
17.2.2 AMAZON FILTERS LTD. 584
17.2.3 GRAVER TECHNOLOGIES, LLC 586
17.2.4 MMS AG 588
17.2.5 ERTELALSOP 589
17.2.6 KASAG SWISS AG 590
17.2.7 FREUDENBERG FILTRATION TECHNOLOGIES SE & CO. KG 591
17.2.8 ANTYLIA SCIENTIFIC 592
17.2.9 FILTROX AG 593
17.2.10 MEMBRANE SOLUTIONS 594
18 RESEARCH METHODOLOGY 595
18.1 RESEARCH DATA 595
18.1.1 SECONDARY DATA 596
18.1.2 PRIMARY DATA 596
18.2 MARKET ESTIMATION METHODOLOGY 598
18.2.1 MARKET SIZE ESTIMATION 598
18.2.2 INSIGHTS OF PRIMARY EXPERTS 600
18.2.3 TOP-DOWN APPROACH 601
18.3 MARKET GROWTH RATE PROJECTIONS 602
18.4 MARKET BREAKDOWN AND DATA TRIANGULATION 603
18.5 RESEARCH ASSUMPTIONS 604
18.6 RESEARCH LIMITATIONS 605
18.7 RISK ANALYSIS 605
19 APPENDIX 606
19.1 DISCUSSION GUIDE 606
19.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 611
19.3 CUSTOMIZATION OPTIONS 613
19.4 RELATED REPORTS 614
19.5 AUTHOR DETAILS 615

ページTOPに戻る

List of Tables/Graphs

TABLE 1 PHARMACEUTICAL FILTRATION MARKET: IMPACT ANALYSIS 68
TABLE 2 LIST OF KEY BIOSIMILARS APPROVED, 2023?2025 69
TABLE 3 PHARMACEUTICAL FILTRATION MARKET: PORTER’S FIVE FORCES ANALYSIS 77
TABLE 4 PHARMACEUTICAL FILTRATION MARKET: ROLE IN ECOSYSTEM 82
TABLE 5 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2022?2024 84
TABLE 6 AVERAGE SELLING PRICE, BY REGION, 2022?2024 85
TABLE 7 IMPORT DATA FOR HS CODE 8421, BY COUNTRY, 2020?2024 (USD THOUSAND) 86
TABLE 8 EXPORT DATA FOR HS CODE 8421, BY COUNTRY, 2020?2024 (USD THOUSAND) 87
TABLE 9 EXPORT VOLUME FOR HS CODE 8421, BY COUNTRY, 2020?2024 (TON) 88
TABLE 10 IMPORT VOLUME FOR HS CODE 8421, BY COUNTRY, 2020?2024 (TON) 89
TABLE 11 PHARMACEUTICAL FILTRATION MARKET: KEY CONFERENCES &
EVENTS, 2025?2027 90
TABLE 12 ADVANCED VIRAL FILTRATION ENABLING SAFE MAB PRODUCTION SCALE-UP 92
TABLE 13 RAPID SCALE-UP OF VIRAL VECTOR FILTRATION FOR COVID-19 VACCINE 93
TABLE 14 HIGH-THROUGHPUT VIRAL FILTRATION OPTIMIZATION 93
TABLE 15 US-ADJUSTED RECIPROCAL TARIFF RATES 94
TABLE 16 CRITICAL COMPONENTS LIKELY EXPOSED TO TARIFF CHANGES 95
TABLE 17 INDICATIVE LIST OF PATENTS IN PHARMACEUTICAL FILTRATION MARKET, 2025 104
TABLE 18 CASE STUDIES OF AI IMPLEMENTATION IN PHARMACEUTICAL FILTRATION MARKET 106
TABLE 19 CLIENT’S READINESS TO ADOPT GENERATIVE AI IN PHARMACEUTICAL FILTRATION MARKET 107
TABLE 20 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 108
TABLE 21 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 109
TABLE 22 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 109
TABLE 23 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 110
TABLE 24 COUNTRY-WISE REGULATORY SCENARIO FOR PHARMACEUTICAL FILTER MANUFACTURERS 111
TABLE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCTS (%) 116
TABLE 26 KEY BUYING CRITERIA, BY END USER 117
TABLE 27 PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, 2023?2030 (USD MILLION) 121
TABLE 28 PHARMACEUTICAL CONSUMABLES MARKET, BY REGION,
2023?2030 (USD MILLION) 121
TABLE 29 NORTH AMERICA: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET,
BY COUNTRY, 2023?2030 (USD MILLION) 122
TABLE 30 EUROPE: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 122
TABLE 31 ASIA PACIFIC: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET,
BY COUNTRY, 2023?2030 (USD MILLION) 123
TABLE 32 LATIN AMERICA: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET,
BY COUNTRY, 2023?2030 (USD MILLION) 123
TABLE 33 MIDDLE EAST: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET,
BY COUNTRY, 2023?2030 (USD MILLION) 123
TABLE 34 GCC COUNTRIES: PHARMACEUTICAL FILTRATION CONSUMABLES MARKET,
BY COUNTRY, 2023?2030 (USD MILLION) 124
TABLE 35 PHARMACEUTICAL FILTERS MARKET, BY REGION, 2023?2030 (USD MILLION) 124
TABLE 36 NORTH AMERICA: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 125
TABLE 37 EUROPE: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 125
TABLE 38 ASIA PACIFIC: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 126
TABLE 39 LATIN AMERICA: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 126
TABLE 40 MIDDLE EAST: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 126
TABLE 41 GCC COUNTRIES: PHARMACEUTICAL FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 127
TABLE 42 PHARMACEUTICAL FILTERS MARKET, BY TYPE, 2023?2030 (USD MILLION) 127
TABLE 43 PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY REGION,
2023?2030 (USD MILLION) 128
TABLE 44 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 129
TABLE 45 EUROPE: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 129
TABLE 46 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 130
TABLE 47 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 130
TABLE 48 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 130
TABLE 49 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 131
TABLE 50 PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY MATERIAL,
2023?2030 (USD MILLION) 131
TABLE 51 POLYETHERSULFONE MEMBRANE FILTERS MARKET, BY REGION,
2023?2030 (USD MILLION) 132
TABLE 52 NORTH AMERICA: POLYETHERSULFONE MEMBRANE FILTERS MARKET,
BY COUNTRY, 2023?2030 (USD MILLION) 132
TABLE 53 EUROPE: POLYETHERSULFONE MEMBRANE FILTERS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 133
TABLE 54 ASIA PACIFIC: POLYETHERSULFONE MEMBRANE FILTERS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 133
TABLE 55 LATIN AMERICA: POLYETHERSULFONE MEMBRANE FILTERS MARKET,
BY COUNTRY, 2023?2030 (USD MILLION) 134
TABLE 56 MIDDLE EAST: POLYETHERSULFONE MEMBRANE FILTERS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 134
TABLE 57 GCC COUNTRIES: POLYETHERSULFONE MEMBRANE FILTERS MARKET,
BY COUNTRY, 2023?2030 (USD MILLION) 134
TABLE 58 POLYVINYLIDENE DIFLUORIDE MEMBRANE FILTERS MARKET, BY REGION,
2023?2030 (USD MILLION) 135
TABLE 59 NORTH AMERICA: PVDF MEMBRANE FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 136
TABLE 60 EUROPE: PVDF MEMBRANE FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 136
TABLE 61 ASIA PACIFIC: PVDF MEMBRANE FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 137
TABLE 62 LATIN AMERICA: PVDF MEMBRANE FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 137
TABLE 63 MIDDLE EAST: PVDF MEMBRANE FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 137
TABLE 64 GCC COUNTRIES: PVDF MEMBRANE FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 138
TABLE 65 NYLON MEMBRANE FILTERS MARKET, BY REGION, 2023?2030 (USD MILLION) 138
TABLE 66 NORTH AMERICA: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 139
TABLE 67 EUROPE: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 139
TABLE 68 ASIA PACIFIC: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 140
TABLE 69 LATIN AMERICA: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 140
TABLE 70 MIDDLE EAST: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 140
TABLE 71 GCC COUNTRIES: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 141
TABLE 72 POLYTETRAFLUOROETHYLENE MEMBRANE FILTERS MARKET, BY REGION,
2023?2030 (USD MILLION) 141
TABLE 73 NORTH AMERICA: POLYTETRAFLUOROETHYLENE MEMBRANE FILTERS MARKET,
BY COUNTRY, 2023?2030 (USD MILLION) 141
TABLE 74 EUROPE: POLYTETRAFLUOROETHYLENE MEMBRANE FILTERS MARKET,
BY COUNTRY, 2023?2030 (USD MILLION) 142
TABLE 75 ASIA PACIFIC: POLYTETRAFLUOROETHYLENE MEMBRANE FILTERS MARKET,
BY COUNTRY, 2023?2030 (USD MILLION) 143
TABLE 76 LATIN AMERICA: POLYTETRAFLUOROETHYLENE MEMBRANE FILTERS MARKET,
BY COUNTRY, 2023?2030 (USD MILLION) 143
TABLE 77 MIDDLE EAST: POLYTETRAFLUOROETHYLENE MEMBRANE FILTERS MARKET,
BY COUNTRY, 2023?2030 (USD MILLION) 144
TABLE 78 GCC COUNTRIES: POLYTETRAFLUOROETHYLENE MEMBRANE FILTERS MARKET,
BY COUNTRY, 2023?2030 (USD MILLION) 144
TABLE 79 MIXED CELLULOSE ESTER & CELLULOSE ACETATE MEMBRANE FILTERS MARKET, BY REGION, 2023?2030 (USD MILLION) 145
TABLE 80 NORTH AMERICA: MIXED CELLULOSE ESTER & CELLULOSE ACETATE MEMBRANE FILTERS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 145
TABLE 81 EUROPE: MIXED CELLULOSE ESTER & CELLULOSE ACETATE MEMBRANE FILTERS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 146
TABLE 82 ASIA PACIFIC: MIXED CELLULOSE ESTER & CELLULOSE ACETATE MEMBRANE FILTERS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 146
TABLE 83 LATIN AMERICA: MIXED CELLULOSE ESTER & CELLULOSE ACETATE MEMBRANE FILTERS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 147
TABLE 84 MIDDLE EAST: MIXED CELLULOSE ESTER & CELLULOSE ACETATE MEMBRANE FILTERS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 147
TABLE 85 GCC COUNTRIES: MIXED CELLULOSE ESTER & CELLULOSE ACETATE MEMBRANE FILTERS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 147
TABLE 86 POLYCARBONATE TRACK-ETCHED MEMBRANE FILTERS MARKET, BY REGION, 2023?2030 (USD MILLION) 148
TABLE 87 NORTH AMERICA: POLYCARBONATE TRACK-ETCHED MEMBRANE FILTERS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 148
TABLE 88 EUROPE: POLYCARBONATE TRACK-ETCHED MEMBRANE FILTERS MARKET,
BY COUNTRY, 2023?2030 (USD MILLION) 149
TABLE 89 ASIA PACIFIC: POLYCARBONATE TRACK-ETCHED MEMBRANE FILTERS MARKET,
BY COUNTRY, 2023?2030 (USD MILLION) 149
TABLE 90 LATIN AMERICA: POLYCARBONATE TRACK-ETCHED MEMBRANE FILTERS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 150
TABLE 91 MIDDLE EAST: POLYCARBONATE TRACK-ETCHED MEMBRANE FILTERS MARKET,
BY COUNTRY, 2023?2030 (USD MILLION) 150
TABLE 92 GCC COUNTRIES: POLYCARBONATE TRACK-ETCHED MEMBRANE FILTERS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 150
TABLE 93 OTHER MEMBRANE FILTER MATERIALS MARKET, BY REGION,
2023?2030 (USD MILLION) 151
TABLE 94 NORTH AMERICA: OTHER MEMBRANE FILTER MATERIALS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 151
TABLE 95 EUROPE: OTHER MEMBRANE FILTER MATERIALS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 152
TABLE 96 ASIA PACIFIC: OTHER MEMBRANE FILTER MATERIALS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 152
TABLE 97 LATIN AMERICA: OTHER MEMBRANE FILTER MATERIALS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 153
TABLE 98 MIDDLE EAST: OTHER MEMBRANE FILTER MATERIALS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 153
TABLE 99 GCC COUNTRIES: OTHER MEMBRANE FILTER MATERIALS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 153
TABLE 100 DEPTH FILTERS MARKET, BY REGION, 2023?2030 (USD MILLION) 154
TABLE 101 NORTH AMERICA: DEPTH FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 155
TABLE 102 EUROPE: DEPTH FILTERS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 155
TABLE 103 ASIA PACIFIC: DEPTH FILTERS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 155
TABLE 104 LATIN AMERICA: DEPTH FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 156
TABLE 105 MIDDLE EAST: DEPTH FILTERS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 156
TABLE 106 GCC COUNTRIES: DEPTH FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 156
TABLE 107 DEPTH FILTERS MARKET, BY MEDIA, 2023?2030 (USD MILLION) 157
TABLE 108 DIATOMACEOUS EARTH FILTERS MARKET, BY REGION, 2023?2030 (USD MILLION) 157
TABLE 109 NORTH AMERICA: DIATOMACEOUS EARTH FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 158
TABLE 110 EUROPE: DIATOMACEOUS EARTH FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 158
TABLE 111 ASIA PACIFIC: DIATOMACEOUS EARTH FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 159
TABLE 112 LATIN AMERICA: DIATOMACEOUS EARTH FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 159
TABLE 113 MIDDLE EAST: DIATOMACEOUS EARTH FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 159
TABLE 114 GCC COUNTRIES: DIATOMACEOUS EARTH FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 160
TABLE 115 CELLULOSE FILTERS MARKET, BY REGION, 2023?2030 (USD MILLION) 160
TABLE 116 NORTH AMERICA: CELLULOSE FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 161
TABLE 117 EUROPE: CELLULOSE FILTERS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 161
TABLE 118 ASIA PACIFIC: CELLULOSE FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 162
TABLE 119 LATIN AMERICA: CELLULOSE FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 162
TABLE 120 MIDDLE EAST: CELLULOSE FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 162
TABLE 121 GCC COUNTRIES: CELLULOSE FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 163
TABLE 122 ACTIVATED CARBON FILTERS MARKET, BY REGION, 2023?2030 (USD MILLION) 163
TABLE 123 NORTH AMERICA: ACTIVATED CARBON FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 164
TABLE 124 EUROPE: ACTIVATED CARBON FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 164
TABLE 125 ASIA PACIFIC: ACTIVATED CARBON FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 165
TABLE 126 LATIN AMERICA: ACTIVATED CARBON FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 165
TABLE 127 MIDDLE EAST: ACTIVATED CARBON FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 165
TABLE 128 GCC COUNTRIES: ACTIVATED CARBON FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 166
TABLE 129 PERLITE FILTERS MARKET, BY REGION, 2023?2030 (USD MILLION) 166
TABLE 130 NORTH AMERICA: PERLITE FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 167
TABLE 131 EUROPE: PERLITE FILTERS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 167
TABLE 132 ASIA PACIFIC: PERLITE FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 168
TABLE 133 LATIN AMERICA: PERLITE FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 168
TABLE 134 MIDDLE EAST: PERLITE FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 168
TABLE 135 GCC COUNTRIES: PERLITE FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 169
TABLE 136 OTHER DEPTH FILTER MEDIA MARKET, BY REGION, 2023?2030 (USD MILLION) 169
TABLE 137 NORTH AMERICA: OTHER DEPTH FILTER MEDIA MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 170
TABLE 138 EUROPE: OTHER DEPTH FILTER MEDIA MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 170
TABLE 139 ASIA PACIFIC: OTHER DEPTH FILTER MEDIA MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 171
TABLE 140 LATIN AMERICA: OTHER DEPTH FILTER MEDIA MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 171
TABLE 141 MIDDLE EAST: OTHER DEPTH FILTER MEDIA MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 171
TABLE 142 GCC COUNTRIES: OTHER DEPTH FILTER MEDIA MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 172
TABLE 143 AIR FILTERS MARKET, BY REGION, 2023?2030 (USD MILLION) 173
TABLE 144 NORTH AMERICA: AIR FILTERS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 173
TABLE 145 EUROPE: AIR FILTERS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 174
TABLE 146 ASIA PACIFIC: AIR FILTERS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 174
TABLE 147 LATIN AMERICA: AIR FILTERS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 175
TABLE 148 MIDDLE EAST: AIR FILTERS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 175
TABLE 149 GCC COUNTRIES: AIR FILTERS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 175
TABLE 150 VIRUS FILTERS MARKET, BY REGION, 2023?2030 (USD MILLION) 176
TABLE 151 NORTH AMERICA: VIRUS FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 176
TABLE 152 EUROPE: VIRUS FILTERS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 177
TABLE 153 ASIA PACIFIC: VIRUS FILTERS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 177
TABLE 154 LATIN AMERICA: VIRUS FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 178
TABLE 155 MIDDLE EAST: VIRUS FILTERS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 178
TABLE 156 GCC COUNTRIES: VIRUS FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 178
TABLE 157 OTHER PHARMACEUTICAL FILTERS MARKET, BY REGION,
2023?2030 (USD MILLION) 179
TABLE 158 NORTH AMERICA: OTHER PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 179
TABLE 159 EUROPE: OTHER PHARMACEUTICAL FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 180
TABLE 160 ASIA PACIFIC: OTHER PHARMACEUTICAL FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 180
TABLE 161 LATIN AMERICA: OTHER PHARMACEUTICAL FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 181
TABLE 162 MIDDLE EAST: OTHER PHARMACEUTICAL FILTERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 181
TABLE 163 GCC COUNTRIES: OTHER PHARMACEUTICAL FILTERS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 181
TABLE 164 OTHER CONSUMABLES MARKET, BY REGION, 2023?2030 (USD MILLION) 182
TABLE 165 NORTH AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 182
TABLE 166 EUROPE: OTHER CONSUMABLES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 183
TABLE 167 ASIA PACIFIC: OTHER CONSUMABLES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 183
TABLE 168 LATIN AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 184
TABLE 169 MIDDLE EAST: OTHER CONSUMABLES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 184
TABLE 170 GCC COUNTRIES: OTHER CONSUMABLES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 184
TABLE 171 OTHER CONSUMABLES MARKET, BY TYPE, 2023?2030 (USD MILLION) 185
TABLE 172 FILTRATION ASSEMBLIES MARKET, BY REGION, 2023?2030 (USD MILLION) 185
TABLE 173 NORTH AMERICA: FILTRATION ASSEMBLIES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 186
TABLE 174 EUROPE: FILTRATION ASSEMBLIES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 186
TABLE 175 ASIA PACIFIC: FILTRATION ASSEMBLIES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 187
TABLE 176 LATIN AMERICA: FILTRATION ASSEMBLIES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 187
TABLE 177 MIDDLE EAST: FILTRATION ASSEMBLIES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 187
TABLE 178 GCC COUNTRIES: FILTRATION ASSEMBLIES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 188
TABLE 179 FILTRATION ASSEMBLIES MARKET, BY TYPE, 2023?2030 (USD MILLION) 188
TABLE 180 MICROFILTRATION ASSEMBLIES MARKET, BY REGION, 2023?2030 (USD MILLION) 189
TABLE 181 NORTH AMERICA: MICROFILTRATION ASSEMBLIES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 189
TABLE 182 EUROPE: MICROFILTRATION ASSEMBLIES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 190
TABLE 183 ASIA PACIFIC: MICROFILTRATION ASSEMBLIES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 190
TABLE 184 LATIN AMERICA: MICROFILTRATION ASSEMBLIES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 191
TABLE 185 MIDDLE EAST: MICROFILTRATION ASSEMBLIES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 191
TABLE 186 GCC COUNTRIES: MICROFILTRATION ASSEMBLIES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 191
TABLE 187 ULTRAFILTRATION ASSEMBLIES MARKET, BY REGION, 2023?2030 (USD MILLION) 192
TABLE 188 NORTH AMERICA: ULTRAFILTRATION ASSEMBLIES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 193
TABLE 189 EUROPE: ULTRAFILTRATION ASSEMBLIES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 193
TABLE 190 ASIA PACIFIC: ULTRAFILTRATION ASSEMBLIES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 194
TABLE 191 LATIN AMERICA: ULTRAFILTRATION ASSEMBLIES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 194
TABLE 192 MIDDLE EAST: ULTRAFILTRATION ASSEMBLIES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 194
TABLE 193 GCC COUNTRIES: ULTRAFILTRATION ASSEMBLIES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 195
TABLE 194 NANOFILTRATION ASSEMBLIES MARKET, BY REGION, 2023?2030 (USD MILLION) 196
TABLE 195 NORTH AMERICA: NANOFILTRATION ASSEMBLIES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 196
TABLE 196 EUROPE: NANOFILTRATION ASSEMBLIES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 197
TABLE 197 ASIA PACIFIC: NANOFILTRATION ASSEMBLIES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 197
TABLE 198 LATIN AMERICA: NANOFILTRATION ASSEMBLIES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 198
TABLE 199 MIDDLE EAST: NANOFILTRATION ASSEMBLIES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 198
TABLE 200 GCC COUNTRIES: NANOFILTRATION ASSEMBLIES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 198
TABLE 201 OTHER FILTRATION ASSEMBLIES MARKET, BY REGION,
2023?2030 (USD MILLION) 199
TABLE 202 NORTH AMERICA: OTHER FILTRATION ASSEMBLIES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 199
TABLE 203 EUROPE: OTHER FILTRATION ASSEMBLIES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 200
TABLE 204 ASIA PACIFIC: OTHER FILTRATION ASSEMBLIES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 200
TABLE 205 LATIN AMERICA: OTHER FILTRATION ASSEMBLIES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 201
TABLE 206 MIDDLE EAST: OTHER FILTRATION ASSEMBLIES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 201
TABLE 207 GCC COUNTRIES: OTHER FILTRATION ASSEMBLIES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 201
TABLE 208 FILTER HOLDERS MARKET, BY REGION, 2023?2030 (USD MILLION) 202
TABLE 209 NORTH AMERICA: FILTER HOLDERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 202
TABLE 210 EUROPE: FILTER HOLDERS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 203
TABLE 211 ASIA PACIFIC: FILTER HOLDERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 203
TABLE 212 LATIN AMERICA: FILTER HOLDERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 204
TABLE 213 MIDDLE EAST: FILTER HOLDERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 204
TABLE 214 GCC COUNTRIES: FILTER HOLDERS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 204
TABLE 215 FILTRATION ACCESSORIES MARKET, BY REGION, 2023?2030 (USD MILLION) 205
TABLE 216 NORTH AMERICA: FILTRATION ACCESSORIES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 205
TABLE 217 EUROPE: FILTRATION ACCESSORIES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 206
TABLE 218 ASIA PACIFIC: FILTRATION ACCESSORIES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 206
TABLE 219 LATIN AMERICA: FILTRATION ACCESSORIES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 207
TABLE 220 MIDDLE EAST: FILTRATION ACCESSORIES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 207
TABLE 221 GCC COUNTRIES: FILTRATION ACCESSORIES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 207
TABLE 222 FILTRATION SYSTEMS MARKET, BY REGION, 2023?2030 (USD MILLION) 208
TABLE 223 NORTH AMERICA: FILTRATION SYSTEMS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 208
TABLE 224 EUROPE: FILTRATION SYSTEMS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 209
TABLE 225 ASIA PACIFIC: FILTRATION SYSTEMS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 209
TABLE 226 LATIN AMERICA: FILTRATION SYSTEMS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 210
TABLE 227 MIDDLE EAST: FILTRATION SYSTEMS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 210
TABLE 228 GCC COUNTRIES: FILTRATION SYSTEMS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 210
TABLE 229 FILTRATION SYSTEMS MARKET, BY TYPE, 2023?2030 (USD MILLION) 211
TABLE 230 SINGLE-USE SYSTEMS MARKET, BY REGION, 2023?2030 (USD MILLION) 212
TABLE 231 NORTH AMERICA: SINGLE-USE SYSTEMS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 212
TABLE 232 EUROPE: SINGLE-USE SYSTEMS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 213
TABLE 233 ASIA PACIFIC: SINGLE-USE SYSTEMS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 213
TABLE 234 LATIN AMERICA: SINGLE-USE SYSTEMS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 214
TABLE 235 MIDDLE EAST: SINGLE-USE SYSTEMS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 214
TABLE 236 GCC COUNTRIES: SINGLE-USE SYSTEMS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 214
TABLE 237 REUSABLE SYSTEMS MARKET, BY REGION, 2023?2030 (USD MILLION) 215
TABLE 238 NORTH AMERICA: REUSABLE SYSTEMS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 215
TABLE 239 EUROPE: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 216
TABLE 240 ASIA PACIFIC: REUSABLE SYSTEMS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 216
TABLE 241 LATIN AMERICA: REUSABLE SYSTEMS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 217
TABLE 242 MIDDLE EAST: REUSABLE SYSTEMS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 217
TABLE 243 GCC COUNTRIES: REUSABLE SYSTEMS MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 217
TABLE 244 PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE,
2023?2030 (USD MILLION) 219
TABLE 245 MICROFILTRATION MARKET, BY REGION, 2023?2030 (USD MILLION) 220
TABLE 246 NORTH AMERICA: MICROFILTRATION MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 220
TABLE 247 EUROPE: MICROFILTRATION MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 220
TABLE 248 ASIA PACIFIC: MICROFILTRATION MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 221
TABLE 249 LATIN AMERICA: MICROFILTRATION MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 221
TABLE 250 MIDDLE EAST: MICROFILTRATION MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 221
TABLE 251 GCC COUNTRIES: MICROFILTRATION MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 222
TABLE 252 ULTRAFILTRATION MARKET, BY REGION, 2023?2030 (USD MILLION) 222
TABLE 253 NORTH AMERICA: ULTRAFILTRATION MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 223
TABLE 254 EUROPE: ULTRAFILTRATION MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 223
TABLE 255 ASIA PACIFIC: ULTRAFILTRATION MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 223
TABLE 256 LATIN AMERICA: ULTRAFILTRATION MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 224
TABLE 257 MIDDLE EAST: ULTRAFILTRATION MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 224
TABLE 258 GCC COUNTRIES: ULTRAFILTRATION MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 224
TABLE 259 NANOFILTRATION MARKET, BY REGION, 2023?2030 (USD MILLION) 225
TABLE 260 NORTH AMERICA: NANOFILTRATION MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 226
TABLE 261 EUROPE: NANOFILTRATION MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 226
TABLE 262 ASIA PACIFIC: NANOFILTRATION MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 226
TABLE 263 LATIN AMERICA: NANOFILTRATION MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 227
TABLE 264 MIDDLE EAST: NANOFILTRATION MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 227
TABLE 265 GCC COUNTRIES: NANOFILTRATION MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 227
TABLE 266 OTHER FILTRATION TECHNIQUES MARKET, BY REGION,
2023?2030 (USD MILLION) 228
TABLE 267 NORTH AMERICA: OTHER FILTRATION TECHNIQUES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 228
TABLE 268 EUROPE: OTHER FILTRATION TECHNIQUES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 229
TABLE 269 ASIA PACIFIC: OTHER FILTRATION TECHNIQUES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 229
TABLE 270 LATIN AMERICA: OTHER FILTRATION TECHNIQUES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 230
TABLE 271 MIDDLE EAST: OTHER FILTRATION TECHNIQUES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 230
TABLE 272 GCC COUNTRIES: OTHER FILTRATION TECHNIQUES MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 230
TABLE 273 PHARMACEUTICAL FILTRATION MARKET, BY TYPE, 2023?2030 (USD MILLION) 232
TABLE 274 STERILE FILTRATION MARKET, BY REGION, 2023?2030 (USD MILLION) 233
TABLE 275 NORTH AMERICA: STERILE FILTRATION MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 233
TABLE 276 EUROPE: STERILE FILTRATION MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 233
TABLE 277 ASIA PACIFIC: STERILE FILTRATION MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 234
TABLE 278 LATIN AMERICA: STERILE FILTRATION MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 234
TABLE 279 MIDDLE EAST: STERILE FILTRATION MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 234
TABLE 280 GCC COUNTRIES: STERILE FILTRATION MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 235
TABLE 281 NON-STERILE FILTRATION MARKET, BY REGION, 2023?2030 (USD MILLION) 235
TABLE 282 NORTH AMERICA: NON-STERILE FILTRATION MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 236
TABLE 283 EUROPE: NON-STERILE FILTRATION MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 236
TABLE 284 ASIA PACIFIC: NON-STERILE FILTRATION MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 236
TABLE 285 LATIN AMERICA: NON-STERILE FILTRATION MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 237
TABLE 286 MIDDLE EAST: NON-STERILE FILTRATION MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 237
TABLE 287 GCC COUNTRIES: NON-STERILE FILTRATION MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 237
TABLE 288 PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION,
2023?2030 (USD MILLION) 239
TABLE 289 PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING,
BY REGION, 2023?2030 (USD MILLION) 240
TABLE 290 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2023?2030 (USD MILLION) 240
TABLE 291 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2023?2030 (USD MILLION) 241
TABLE 292 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2023?2030 (USD MILLION) 241
TABLE 293 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2023?2030 (USD MILLION) 242
TABLE 294 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2023?2030 (USD MILLION) 242
TABLE 295 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2023?2030 (USD MILLION) 242
TABLE 296 PHARMACEUTICAL FILTRATION MARKET FOR FINAL PRODUCT PROCESSING,
BY TYPE, 2023?2030 (USD MILLION) 243
TABLE 297 ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY REGION,
2023?2030 (USD MILLION) 244
TABLE 298 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET,
BY COUNTRY, 2023?2030 (USD MILLION) 244
TABLE 299 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET,
BY COUNTRY, 2023?2030 (USD MILLION) 245
TABLE 300 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET,
BY COUNTRY, 2023?2030 (USD MILLION) 245
TABLE 301 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET,
BY COUNTRY, 2023?2030 (USD MILLION) 246
TABLE 302 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET,
BY COUNTRY, 2023?2030 (USD MILLION) 246
TABLE 303 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET,
BY COUNTRY, 2023?2030 (USD MILLION) 246
TABLE 304 PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY REGION, 2023?2030 (USD MILLION) 247
TABLE 305 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY COUNTRY, 2023?2030 (USD MILLION) 248
TABLE 306 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION,
BY COUNTRY, 2023?2030 (USD MILLION) 248
TABLE 307 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY COUNTRY, 2023?2030 (USD MILLION) 249
TABLE 308 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY COUNTRY, 2023?2030 (USD MILLION) 249
TABLE 309 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY COUNTRY, 2023?2030 (USD MILLION) 249
TABLE 310 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR PROTEIN PURIFICATION, BY COUNTRY, 2023?2030 (USD MILLION) 250
TABLE 311 PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY REGION, 2023?2030 (USD MILLION) 251
TABLE 312 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY COUNTRY, 2023?2030 (USD MILLION) 251
TABLE 313 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY COUNTRY, 2023?2030 (USD MILLION) 252
TABLE 314 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY COUNTRY, 2023?2030 (USD MILLION) 252
TABLE 315 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY COUNTRY, 2023?2030 (USD MILLION) 253
TABLE 316 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY COUNTRY, 2023?2030 (USD MILLION) 253
TABLE 317 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR VACCINE AND ANTIBODY PROCESSING, BY COUNTRY, 2023?2030 (USD MILLION) 253
TABLE 318 PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTIONS, BY REGION, 2023?2030 (USD MILLION) 254
TABLE 319 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTIONS, BY COUNTRY, 2023?2030 (USD MILLION) 254
TABLE 320 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTIONS, BY COUNTRY, 2023?2030 (USD MILLION) 255
TABLE 321 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTIONS, BY COUNTRY, 2023?2030 (USD MILLION) 255
TABLE 322 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTIONS, BY COUNTRY, 2023?2030 (USD MILLION) 256
TABLE 323 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTIONS, BY COUNTRY, 2023?2030 (USD MILLION) 256
TABLE 324 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR FORMULATION AND FILLING SOLUTIONS, BY COUNTRY, 2023?2030 (USD MILLION) 256
TABLE 325 PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE, BY REGION, 2023?2030 (USD MILLION) 257
TABLE 326 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE, BY COUNTRY, 2023?2030 (USD MILLION) 258
TABLE 327 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE,
BY COUNTRY, 2023?2030 (USD MILLION) 258
TABLE 328 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE,
BY COUNTRY, 2023?2030 (USD MILLION) 259
TABLE 329 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE, BY COUNTRY, 2023?2030 (USD MILLION) 259
TABLE 330 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE,
BY COUNTRY, 2023?2030 (USD MILLION) 259
TABLE 331 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR VIRAL CLEARANCE, BY COUNTRY, 2023?2030 (USD MILLION) 260
TABLE 332 PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY REGION, 2023?2030 (USD MILLION) 260
TABLE 333 NORTH AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2023?2030 (USD MILLION) 261
TABLE 334 EUROPE: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2023?2030 (USD MILLION) 261
TABLE 335 ASIA PACIFIC: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2023?2030 (USD MILLION) 262
TABLE 336 LATIN AMERICA: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2023?2030 (USD MILLION) 262
TABLE 337 MIDDLE EAST: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2023?2030 (USD MILLION) 262
TABLE 338 GCC COUNTRIES: PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY COUNTRY, 2023?2030 (USD MILLION) 263
TABLE 339 PHARMACEUTICAL FILTRATION MARKET FOR RAW MATERIAL FILTRATION, BY TYPE, 2023?2030 (USD MILLION) 263TABLE 340 PHARMACEUTICAL FILTRAT